采纳股份收盘下跌1.49%，滚动市盈率72.57倍，总市值25.93亿元

Company Overview - Company name is采纳科技股份有限公司, primarily engaged in the research, production, and sales of injection puncture instruments and laboratory consumables [1] - Main products include medical devices, animal instruments, and laboratory consumables [1] - Recognized as a specialized and innovative small and medium-sized enterprise in Jiangsu Province and a provincial-level leading enterprise in agricultural industrialization [1] Financial Performance - As of Q1 2025, the company reported revenue of 72.71 million yuan, a year-on-year decrease of 34.28% [1] - Net profit for the same period was 7.68 million yuan, down 69.34% year-on-year [1] - Gross profit margin stood at 31.15% [1] Market Position - The company's closing stock price was 21.21 yuan, down 1.49%, with a rolling PE ratio of 72.57 times [1] - Total market capitalization is 2.593 billion yuan [1] - In comparison to the medical device industry, which has an average PE ratio of 51.05 times and a median of 36.62 times, the company ranks 99th [1][2] Institutional Holdings - As of Q1 2025, five institutions held shares in the company, with a total holding of 25.89 million shares valued at 57.1 million yuan [1]